A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
Completed
Galderma
Phase 2
2006-08-01
This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the
adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied
twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous
areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will
be collected during the first 3 weeks of the study; safety and efficacy data will be
collected for the 8 weeks of the treatment.
A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
Completed
Galderma R&D
Phase 2
2006-08-01
This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the
adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied
twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous
areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will
be collected during the first 3 weeks of the study; safety and efficacy data will be
collected for the 8 weeks of the treatment.
Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis
Completed
Galderma Laboratories, L.P.
Phase 4
2009-10-01
This clinical trial will evaluate the efficacy and safety of Clobex® (clobetasol propionate)
Spray 0.05% and Vectical™ (calcitriol) Ointment 3 µg/g over a four week period of use in one
of two different regimens:
1. Vectical™ Ointment treatment, twice daily on weekdays (Mon - Fri) and Clobex® Spray
treatment twice daily on weekends (Sat - Sun) for 28 days
2. Clobex® Spray once each morning and Vectical™ Ointment once each evening for 28 days
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
